Keyphrases
Pancreatic Cancer
100%
Neoantigen Vaccine
100%
TIGIT
100%
PD-1 Blockade
100%
Pancreatic Ductal Adenocarcinoma
50%
Neoantigen
40%
Programmed Death-ligand 1 (PD-L1)
40%
Tumor
20%
Tumor Growth
20%
T Cell Response
20%
Signaling Pathway
20%
Translational Studies
20%
Specific T Cells
20%
Cancer Neoantigens
20%
Poly IC
10%
Toll-like
10%
T Cell Activation
10%
Cancer Types
10%
CDK12
10%
Genetic Modification
10%
Human Pancreatic Ductal Adenocarcinoma
10%
Vaccination
10%
Cell Tumor
10%
Receptor Agonist
10%
Study Support
10%
Cancer Immunotherapy
10%
Regulatory Mechanism
10%
Synthetic Peptides
10%
Therapeutic Efficacy
10%
Tumor Regression
10%
Immunogenic
10%
Immune Regulation
10%
Vaccine Response
10%
T Cell Depletion
10%
Antigen-specific T Cell Response
10%
Tumor-bearing Mice
10%
CD155
10%
Immune Checkpoint Signaling
10%
Immunology and Microbiology
Neoantigen
100%
T Cell
40%
Immunity
13%
Polyinosinic:polycytidylic Acid
6%
Cell Function
6%
Agonist
6%
Cancer Immunotherapy
6%
Gene Mutation
6%
Programmed Death-Ligand 1
6%
CD155
6%
Toll-Like Receptor
6%
Peptides
6%